Rainer Fuchs

Director/Board Member at Egenix, Inc.

Health Technology

Profile

Dr. Rainer Fuchs is Chairman & President at Provasculon, Inc. He is on the Board of Directors at Egenix, Inc. Dr. Fuchs was previously employed as President by Escoublac, Inc.

Rainer Fuchs active positions

Companies	Position	Start
Egenix, Inc. Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million.	Director/Board Member	05/11/2012

All active positions of Rainer Fuchs

Former positions of Rainer Fuchs

Companies	Position	End
Escoublac, Inc. Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA.	President	-
Provasculon, Inc. Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA.	Chairman	-

See the detail of Rainer Fuchs's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rainer Fuchs's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Provasculon, Inc. Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA.	Health Technology
Escoublac, Inc. Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA.	Health Technology
Egenix, Inc. Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million.	Health Technology

See company connections

Stock Market
Insiders
Rainer Fuchs